Yale Equity Reseach and Innovation Center (ERIC)

@eric-ysm.bsky.social

Equity Research & Innovation Center (ERIC) @ Yale focuses on health/care disparities research. Founded by Dr. Marcella Nunez-Smith. Posts are from ERIC.

Of the 172 medicines approved by the FDA from 2015-18, only 24% of countries had physical access to every drug they helped test, even after 5 years, with lowest access in African countries. New research from ERIC Affiliate Faculty Jen Miller, PhD and team lays it out clearly: tinyurl.com/ycxehhy4

Physical Accessibility of Medicines in Countries Hosting Trials for FDA Approvals

This cross-sectional study aims to determine whether and when medicines receive market authorization in the countries where they are tested for US Food and Drug Administration approval, as well as…

tinyurl.com

In 2023, cancer caused nearly 1 in 6 deaths worldwide, with over 2/3 of those deaths occurring in low- and middle-income countries, where access to screening and treatment remains limited. Here’s why this growing crisis demands our attention, and why the next 25 years is critical. bit.ly/48FoKGa

The world is facing a cancer crisis that’s hitting the most vulnerable hardest

Cancer is a universal challenge that hits those with the fewest resources hardest – and nearly half of global cancer deaths are linked to preventable risks.

bit.ly

🌍 #Africa bears 25% of the disease burden but hosts only 4% of clinical trials. 💡 “Africa is critical for advancing science and for ensuring medicines work for everyone.” Unlocking this potential means investment, collaboration, and stronger systems. #IFPMA @h3dfoundation.bsky.social 📖⬇️ & 🙏🔁

Collaboration Across Africa Is Key To Increasing Clinical Trials - Health Policy Watch

In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for

healthpolicy-watch.news